Correlation Between FitLife Brands, and Mineralys Therapeutics,

Can any of the company-specific risk be diversified away by investing in both FitLife Brands, and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FitLife Brands, and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between FitLife Brands, Common and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on FitLife Brands, and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FitLife Brands, with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of FitLife Brands, and Mineralys Therapeutics,.

Diversification Opportunities for FitLife Brands, and Mineralys Therapeutics,

-0.02

Correlation Coefficient

FitLife Brands,  Mineralys Therapeutics,

Good diversification

The 3 months correlation between FitLife and Mineralys is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding FitLife Brands, Common and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and FitLife Brands, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FitLife Brands, Common are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of FitLife Brands, i.e., FitLife Brands, and Mineralys Therapeutics, go up and down completely randomly.

Pair Corralation between FitLife Brands, and Mineralys Therapeutics,

Given the investment horizon of 90 days FitLife Brands, Common is expected to under-perform the Mineralys Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, FitLife Brands, Common is 3.06 times less risky than Mineralys Therapeutics,. The stock trades about -0.1 of its potential returns per unit of risk. The Mineralys Therapeutics, Common is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  1,206  in Mineralys Therapeutics, Common on December 21, 2024 and sell it today you would earn a total of  467.00  from holding Mineralys Therapeutics, Common or generate 38.72% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

FitLife Brands, Common  vs.  Mineralys Therapeutics, Common

FitLife Brands, Common

Risk-Adjusted Performance

Very Weak

Over the last 90 days FitLife Brands, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's essential indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Mineralys Therapeutics,

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Mineralys Therapeutics, unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with FitLife Brands, and Mineralys Therapeutics,

The main advantage of trading using opposite FitLife Brands, and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FitLife Brands, position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.

The idea behind FitLife Brands, Common and Mineralys Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.